Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.
Diagnostics Biochem Canada Inc.
6 enregistrements totalisant 1,632,804.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Défense nationale | $1,014,000 | 1 enregistrement |
| Conseil national de recherches Canada | $618,804 | 5 enregistrements |
Enregistrements
Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 202...
This project comprises developing enzyme-linked-immunosorbent assays (ELISAs) for the quantitative determination of hormones in human saliva—an analyte matrix that, in contrast to blood, enables non-i...
To prepare, dispense and test diagnostic kits, including COVID-19 test kits, and ensure they are working properly before being released.
Develop of immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually
DBC is aiming to expand its global reach to the Emirati market. DBC's main objective is to demonstrate the quality and wide-range of its products in order to acquire new potential distributors and end...